# Robert J. Mentz

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/robert-j-mentz/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,556 |
| Field | Heart Failure Treatment and Management |
| h-index | 87 |
| i10-index | 400 |
| Last Known Institution | Duke University |
| OpenAlex ID | https://openalex.org/A5068642565 |
| ORCID iD | 0000-0002-3222-1719 |
| Works | 981 |

## Researcher papers

Showing 12 of 18.

- [2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure](https://scholariq.org/papers/2023-focused-update-of-the-2021-esc-guidelines-for-the-diagnosis-and-treatment/)
- [Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes](https://scholariq.org/papers/effects-of-once-weekly-exenatide-on-cardiovascular-outcomes-in-type-2-diabetes/)
- [The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial](https://scholariq.org/papers/the-sglt2-inhibitor-empagliflozin-in-patients-hospitalized-for-acute-heart/)
- [Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update](https://scholariq.org/papers/type-2-diabetes-mellitus-and-heart-failure-a-scientific-statement-from-the/)
- [Palliative Care in Heart Failure](https://scholariq.org/papers/palliative-care-in-heart-failure/)
- [Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis](https://scholariq.org/papers/cardiovascular-outcomes-with-glucagon-like-peptide-1-receptor-agonists-in/)
- [Physical Rehabilitation for Older Patients Hospitalized for Heart Failure](https://scholariq.org/papers/physical-rehabilitation-for-older-patients-hospitalized-for-heart-failure/)
- [Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection Fraction](https://scholariq.org/papers/noncardiac-comorbidities-in-heart-failure-with-reduced-versus-preserved-ejection/)
- [Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction](https://scholariq.org/papers/dapagliflozin-effects-on-biomarkers-symptoms-and-functional-status-in-patients/)
- [Impact of Diabetes on Epidemiology, Treatment, and Outcomes of Patients With Heart Failure](https://scholariq.org/papers/impact-of-diabetes-on-epidemiology-treatment-and-outcomes-of-patients-with-heart/)
- [Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure](https://scholariq.org/papers/relief-and-recurrence-of-congestion-during-and-after-hospitalization-for-acute/)
- [Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial](https://scholariq.org/papers/patiromer-for-the-management-of-hyperkalemia-in-heart-failure-with-reduced/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)
- [Cardiovascular and exercise physiology](https://scholariq.org/topics/cardiovascular-and-exercise-physiology/)

## Researcher university

- [Duke University](https://scholariq.org/institutions/duke-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.